DOMME Dose Optimization Multicentric Mexican Evaluation
NCT00488527
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
371
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Insulin glargine
Sponsor
Sanofi